A 54-year-old man presents to your office 1 year after undergoing sigmoid resection for T3N0 colon cancer. In addition to carcinoembryonic antigen, what surveillance approach do you recommend?

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.